Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

NCT00031850 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: goserelin acetate
DRUG: raloxifene

Sponsor

Institute of Cancer Research, United Kingdom